黑料网

Journal of Diabetes & Clinical Practice
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Perspective   
  • JDCE,
  • DOI: 10.4172/jdce.1000170

Neglected Factor during Cancer Progression by Hyperglycemia

Laura Soysal*
Department of Internal Medicine, University of Katip Celebi and Ataturk Research and Training Hospital, Turkey
*Corresponding Author : Laura Soysal, Department of Internal Medicine, University of Katip Celebi and Ataturk Research and Training Hospital, Turkey, Email: LauraSoysal90@gmail.com

Received Date: Nov 01, 2022 / Accepted Date: Nov 30, 2022 / Published Date: Nov 30, 2022

Abstract

Recent data from sizable cohort studies shows that persons with type 2 diabetes have a greater cancer incidence. The probable causes of this relationship are yet unknown, though, as of this writing. These glucosehungry cells may get extra glucose from hyperglycemia, the most significant aspect of diabetes, which also leads to oncogenesis, apoptosis resistance, and chemotherapy-resistant tumour cells [1]. The impact of hyperglycemia on the advancement of cancer in cancer patients with abnormal blood glucose levels should not be disregarded given the link between diabetes and malignancies [2]. In this article, we discuss the role that hyperglycemia plays in the development of cancer and its management, as well as how it might influence the phenotypic of cancer cells and promote drug resistance. Consequently, managing hyperglycemia may Hyperglycemia, also known as high blood glucose, is a condition that occurs when there is either an insufficient quantity of insulin in the body or when the body is unable to properly utilise the insulin that is present [3].

Citation: Soysal L (2022) Neglected Factor during Cancer Progression by Hyperglycemia. J Diabetes Clin Prac 5: 170. Doi: 10.4172/jdce.1000170

Copyright: © 2022 Soysal L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top